Life-saving drug treatment for up to 1.7m people with HIV is under threat because of funding pressures triggered by the global financial crisis, according to an analysis released yesterday by the World Bank.

A survey of the impact of the economic downturn on 69 of the globe's poorest countries showed that 15 believed they were "highly exposed" to the risk of interrupting anti-retroviral medicines from declines in external and domestic funding.